Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes

Table 3

Baseline and 12-month BCVA and CRT related to the numbers of implants.

	Nonvitrectomized eyes ()	Vitrectomized eyes ()	P value
Baseline Snellen BCVA	0.20 (0.0–1.0)	0.10 (0.01–0.40)	0.282
12-month Snellen BCVA	0.33 (0.01–1.0)	0.45 (0.01–0.80)	0.418
Number of implants	1.0 (1.0–3.0)	3.0 (1.0–5.0)	<0.001
Baseline CRT (microns)	420 (243–920)	532 (214–840)	0.199
12-month CRT (microns)	265 (194–977)	232 (154–741)	0.300

By the Mann-Whitney test.
Data are expressed as the mean (minimum–maximum).
BCVA, best-corrected visual acuity; CRT, central retinal thickness.